Chimerix News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.12.23	Chimerix Appoints Michelle LaSpaluto As CFO (RTTNews)
25.07.22	Pre-market Movers: CMRX, FAZE, NRGV, SIGA, IH… (RTTNews)
23.05.22	Pre-market Movers: SIGA, VMW, EVTL, TNXP, EBS… (RTTNews)
16.05.22	Emergent BioSolutions To Acquire TEMBEXA Rights From Chimerix For Up To $337.5 Mln + Royalties (RTTNews)
08.01.21	Stock Alert: Chimerix Surges 60% On Acquisition Of Oncoceutics (RTTNews)
08.12.20	BLCM Hit With Clinical Hold, LANTERN Fails To Light Up LYRA, TNXP Gains, FDA Says No To SCPH (RTTNews)
08.10.20	CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch (RTTNews)
29.04.20	Stock Alert: Chimerix Shares Up 35% In Premarket (RTTNews)
14.05.19	5 Top Gainers In Pharma Sector (TWST, NOVN, CMRX…) (RTTNews)
10.04.19	6 Top Gainers In Healthcare Sector (CMRX, PRVB, MOTS...) (RTTNews)
15.09.18	Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...) (RTTNews)
09.06.18	An Ear To The Pharma: 8 Stocks To Watch (CMRX, CRBP, KPTI, VRX…) (RTTNews)
03.05.17	Gainers & Losers Of May 2: MOH, RGLS, EYES, APHB, CMRX... (RTTNews)
27.04.17	Research Reports Coverage on Biotech Stocks -- Ultragenyx Pharma, Chimerix, Coherus Biosciences, and Omeros (PR Newswire)
24.01.17	Gainers & Losers Of The Day: ACST, MRNS, BIOA, APTO, PULM... (RTTNews)
18.01.17	Research Reports Coverage on Biotech Stocks -- Emergent BioSolutions, Chimerix, VIVUS, and RXi Pharma (PR Newswire)
09.02.16	BCRX Heartbroken, FLML Opens Wallet, SRPT In The News, CUTR Optimistic (RTTNews)
31.12.15	Point72 Asset Management Discloses 5.3% Stake In Chimerix (RTTNews)
28.12.15	Chimerix :Phase 3 SUPPRESS Trial Of Brincidofovir Fails To Meet Primary Endpoint (RTTNews)
04.08.15	ISIS Does It Again, LXRX Shines On TELESTAR Data, ACRX Awaits EC Approval (RTTNews)
24.07.15	Eagle's Flying High, Sunesis Plunges On FDA Feedback, There's No Stopping Inotek (RTTNews)
09.06.15	OCLS Gets A Facelift, NBIX Halts Trials, CBYL For The Long Haul, CMRX On Track (RTTNews)
27.02.15	STAR Lights Up CYTX, NVAX Awaits Catalysts, VTAE Thrashed, CMRX On Watch (RTTNews)
13.02.15	ADHD Needs Your Attention, MOH In Good Health, GNCA Awaits Catalysts (RTTNews)
02.02.15	Shire's Vyvanse Gets Attention, CMRX Bids Adieu To Ebola Trials, VTL On Watch (RTTNews)
01.02.15	Chimerix To Cease Participation In Clinical Studies Of Ebola Drug (RTTNews)
08.10.14	Chimerix' Brincidofovir Shows Potential Survival Benefit In Adenovirus Infection (RTTNews)
07.10.14	ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod (RTTNews)
06.10.14	Chimerix Announces Emergency Investigational NDA For Brincidofovir (RTTNews)
07.08.14	Chimerix Net Loss Reduces In Q2 - Quick Facts (RTTNews)
21.05.14	Chimerix Prices Public Offering Of 7.3 Mln Shares At $14.22/Shr - Quick Facts (RTTNews)
19.05.14	Chimerix Announces Public Offering Of 6.2 Mln Shares (RTTNews)
16.05.14	Chimerix Regains Worldwide Rights To CMX157 From Merck - Quick Facts (RTTNews)
09.05.14	Chimerix Posts Wider-than-expected Q1 Loss; Revenues Miss - Quick Facts (RTTNews)
09.04.14	Chimerix CEO Resigns, Names Replacement (RTTNews)
07.03.14	Chimerix Q4 Loss Widens - Quick Facts (RTTNews)
14.11.13	Chimerix Slips To Loss In Q3 - Quick Facts (RTTNews)
26.09.13	Chimerix Reports Positive Phase 2 Results Of Brincidofovir - Quick Facts (RTTNews)
09.09.13	Chimerix Begins Dosing In Phase 3 SUPPRESS Trial Of Brincidofovir (RTTNews)
14.08.13	Chimerix Reports Encouraging Results From CMX001 Phase 2 Adenovirus Trial (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Chimerix Inc

Aktien Top/Flop

Meistgelesene Nachrichten